Very interesting discovery Titus!
Yes, sells Inhibitex to BMS for US$2.5billion, largely on the back of INX-189 HepC antiviral which BMS subsequently rename BMS-986094 and which is held responsible for a patient fatality, resulting in the discontinuation of the drug's development.
Reads like a scene from a movie.
Is this guy really JR Ewing in disguise??
Possibly a little more research required here.
- Forums
- ASX - By Stock
- BTA
- proposed new ceo is
proposed new ceo is, page-11
-
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online